Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

Presented by

Synopsis

Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In the absence of guidelines, there is wide disparity in the management of patients with these premalignant conditions. The European Society of Gastrointestinal Endoscopy (ESGE), the European Helicobacter Study Group (EHSG), the European Society of Pathology (ESP) and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) have therefore combined efforts to develop evidence- based guidelines on the management of patients with precancerous conditions and lesions of the stomach (termed MAPS). A multidisciplinary group of 63 experts from 24 countries developed these recommendations by means of repeat online voting and a meeting in June 2011 in Porto, Portugal. The recommendations emphasize the increased cancer risk in patients with gastric atrophy and metaplasia, and the need for adequate staging in the case of high grade dysplasia, and they focus on treatment and surveillance indications and methods.

Keywords: gastric intestinal metaplasia; serum pepsinogen-I; chronic atrophic gastritis; randomized controlled trial; term follow-up; cost-effectiveness analysis; high-risk population; cytokine gene polymorphisms; inflammatory bowel disease; pylori-related gastritis

Available Languages

English

Source File

Publishing organization(s):

ESP European Society of Pathology, Sociedade Portuguesa de Endoscopia Digestiva (SPED)

Scientific area:

Endoscopy, Histopathology, Digestive Oncology
  


This item can be cited as: Endoscopy 2012; 44: 74–94; PMID 22198778

Categorisation:

  • Format
    • Standards and Guidelines
  • Language
    • English
  • UEG Member Society
    • European Helicobacter and Microbiota Study Group (EHMSG)
    • European Society of Gastrointestinal Endoscopy (ESGE)
  • UEG Week Pathway
    • Digestive Oncology
    • Endoscopy
    • Histopathology
  • Year
    • 2012